Gómez-Dabó, Laura
Melgarejo-Martínez, Laura
Caronna, Edoardo http://orcid.org/0000-0001-5525-0267
Pozo-Rosich, Patricia
Article History
Accepted: 21 July 2023
First Online: 4 September 2023
Declarations
:
: LGD reports no disclosures. LMM reports no disclosures. EC has received honoraria from Novartis, Chiesi, Lundbeck, MedScape; his salary has been partially funded by Río Hortega grant Acción Estratégica en Salud 2017–2020, Instituto de Salud Carlos III (CM20/00217). He is a junior editor for <i>Cephalalgia</i>. PPR has received, in the last three years, honoraria as a consultant and speaker for: AbbVie, Biohaven, Chiesi, Eli Lilly, Lundbeck, Medscape, Novartis, Pfizer, and Teva. Her research group has received research grants from AbbVie, Novartis and Teva; as well as, Instituto Salud Carlos III, EraNet Neuron, European Regional Development Fund (001-P-001682) under the framework of the FEDER Operative Programme for Catalunya 2014-2020 - RIS3CAT; has received funding for clinical trials from AbbVie, Amgen, Biohaven, Eli Lilly, Novartis, and Teva. She is the Honorary Secretary of the International Headache Society. She is in the editorial board of Revista de Neurologia. She is an associate editor for <i>Cephalalgia</i>, <i>Headache</i>, <i>Neurologia</i>, <i>The Journal of Headache and Pain</i>, and <i>Frontiers of Neurology</i>. She is a member of the Clinical Trials Guidelines Committee of the International Headache Society. She has edited the Guidelines for the Diagnosis and Treatment of Headache of the Spanish Neurological Society. She is the founder of ExternalRef removed. PPR does not own stocks from any pharmaceutical company.
: This article does not contain any studies with human or animal subjects performed by any of the authors.